This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » A1c

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

WelChol Improves Glycemic Control and Cholesterol in Uncontrolled Type 2’s

Posted: Wednesday, November 22, 2006

This is the first study ever to evaluate WelChol in combination with insulin, and it demonstrated A1C reductions of 0.5%

More Treatment Options for Diabetes Means Few Excuses for High Blood Sugar

Posted: Thursday, November 16, 2006

A generation ago, there was just one kind of pill that could help people with diabetes keep their blood sugar levels down. But today, so many new options are available that it's almost dizzying. Advertisements for the new medicines seem to be everywhere, and more new medicines are on the way.

Acomplia ™(Rimonabant) Receives 1st Marketing Authorization in North America

Posted: Thursday, November 16, 2006

Acomplia™ (rimonabant) approved in Mexico to treat obese/overweight patients with associated type 2 diabetes or dyslipidemia or to help them improve glycemic control on background of conventional antidiabetic treatment.

Importance of Fasting Hyperglycemia Dependent on HbA1c

Posted: Thursday, November 09, 2006

Study concluded that the contribution of fasting hyperglycemia was greater in patients with increased HbA1c.

Increasing A1c Levels Predicts Progession to Type 1 Diabetes

Posted: Thursday, November 02, 2006

Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).

Importance of Fasting Hyperglycemia Varies, Depending on HbA1c

Posted: Wednesday, October 25, 2006

Treating fasting blood sugars when the A1c is elevated, has a greater impact on the resulting A1c.

Exenatide As Effective As Insulin

Posted: Thursday, October 12, 2006

Patients on exenatide lost weight, while insulin patients gained weight.

New Diabetes Drug Galvus Matches Avandia in Control of Blood Sugars

Posted: Thursday, October 12, 2006

The new diabetes drug from Novartis, Galvus cuts blood sugar levels as much as GlaxoSmithKlines established medicine Avandia and without the side effects.

New Joint Guidelines for CVD and Diabetes from 2 European Associations

Posted: Thursday, October 12, 2006

Diabetes and cardiovascular diseases (CVD) often appear as the two sides of a coin: on one side, diabetes has been rated as an equivalent of coronary heart disease, and conversely, many patients with established coronary heart disease (65-70 %) suffer from diabetes or its pre-states.

Small Changes in Diabetes Care Exceeds All Expections

Posted: Thursday, October 05, 2006

A series of fairly low-tech innovations radically transformed diabetes care in a busy family medicine program in just over a year's time, exceeding insurance company pay-for-performance benchmarks.